Actipulse Neuroscience Begins a Public Fundraising to Finance FDA Pivotal Trial of Proprietary Neuromodulation Medical Device

Jul 8, 2021

The company aims to advance fast and effective development of an at-home neuromodulation device for Major Depressive Disorder treatment.



CAMBRIDGE, Mass. - July 8, 2021 - (Newswire.com)

Actipulse Neuroscience, a medical company advancing neuromodulation treatments worldwide, today announces it has begun a fundraising campaign with the goal of financing the pivotal trial of a proprietary neuromodulation medical device. Going from July 6 until the end of October, the aim is to raise a total of $1.2 million.

Actipulse Neuroscience is a Boston-based company and specializes in the clinical research of brain stimulation therapeutics that can be used for the treatment of diverse neurological and psychiatric disorders. Currently in the revenue phase for the treatment of Major Depressive Disorder in a hospital-setting, and under clinical trials for Alzheimer's Disease, the technology deploys high-frequency and low-intensity magnetic pulses to achieve a therapeutic effect, non-invasively.

"The funding injection will allow us to finance our clinical pipeline and ultimately bring neuromodulation treatment from the hospital to the home, as there are not enough hospital places to treat the 17 M+ Americans suffering from MDD," says Adrien Châtillon, the Chief Executive Officer and Co-founder. "The objective of Actipulse is not to become a 1 billion dollar company, but a '1 billion patient company,' meaning that our raison d'être, will always be to put the patient first." 

In line with that philosophy, Actipulse Neuroscience has decided to pursue a public investment campaign. Having already secured funds from sales revenue, any financial benefit from this fundraising will be exclusively directed towards the clinical trial. The company's mission is to democratize access to better and affordable mental healthcare, and raising public investment allows it to keep control over the final pricing of the device once approved for sale in the U.S.

The funding is being raised on the Republic's platform. Actipulse Neuroscience has already introduced a hospital-setting device in LATAM countries to test product-market fit, and is preparing to launch an at-home device for depression treatment in the U.S. market, aiming for FDA clearance by Q3 of 2023. 

Since the beginning of the Covid-19 pandemic, around four in 10 adults in the United States have reported symptoms of depressive disorder and anxiety, up from one in 10 adults in 2019. Non-invasive brain stimulation has been used to provide a painless and non-pharmacological treatment to patients; with its compact and friendly-to-use design, Actipulse Neuroscience aims to enable a smarter application of the therapy.

More information on the campaign: https://republic.co/actipulse 

About Actipulse Neuroscience

Actipulse Neuroscience is a medical company specialized in the clinical research of Non-Invasive Brain Stimulation therapeutics for the treatment of neurological and psychiatric disorders, focused on bringing neuromodulation treatment from the hospital to the home.

About Republic

Republic is a platform where both accredited and non-accredited investors meet entrepreneurs and access high-growth potential deals across a range of private markets.

CONTACT

Name: Alice Mior
Phone: +57 312 8113601
Email: [email protected]




Press Release Service by Newswire.com

Original Source: Actipulse Neuroscience Begins a Public Fundraising to Finance FDA Pivotal Trial of Proprietary Neuromodulation Medical Device

More News

October Horoscope 2026: 3 zodiac signs could attract more money but not in the way they expect
Sep 28, 2026
October Horoscope 2026: 3 zodiac signs could attract more money but not in the way they expect

October 2026 could bring a financial turning point for three zodiac signs. Venus and Mercury are both retrograde during the month. In astrology, these periods can bring old opportunities back into focus. For these three signs, money and success could become important themes.

I-T searches premises linked to film producers Kumar Mangat Pathak, Vashu Bhagnani
Sep 28, 2026
I-T searches premises linked to film producers Kumar Mangat Pathak, Vashu Bhagnani

The Income Tax Department on Monday searched multiple Mumbai locations linked to Panorama Studios and film producers Kumar Mangat Pathak and Vashu Bhagnani over suspected irregularities involving foreign remittances and alleged tax evasion, sources said. Officials examined financial records and overseas transaction details as part of the ongoing probe.

I-T searches premises linked to film producers Kumar Mangat Pathak, Vashu Bhagnani
Sep 28, 2026
I-T searches premises linked to film producers Kumar Mangat Pathak, Vashu Bhagnani

The Income Tax Department on Monday searched multiple Mumbai locations linked to Panorama Studios and film producers Kumar Mangat Pathak and Vashu Bhagnani over suspected irregularities involving foreign remittances and alleged tax evasion, sources said. Officials examined financial records and overseas transaction details as part of the ongoing probe.

Beijing widens travel curbs to kin of top chip, AI talent
Sep 28, 2026
Beijing widens travel curbs to kin of top chip, AI talent

Government agencies have recently begun to share the wider restrictions with affected people, which include prominent startup founders as well as the heads of strategically important companies in AI-related fields, people familiar with the matter said. Direct relatives such as spouses and children of certain AI and chip executives, whose work is considered paramount to state security, are now required to obtain approval from Beijing before going abroad even for short trips, the people said.

Bangladesh PM Rahman plans Japan, Saudi, Turkey trips; India visit still uncertain
Sep 28, 2026
Bangladesh PM Rahman plans Japan, Saudi, Turkey trips; India visit still uncertain

Bangladesh Prime Minister Tarique Rahman is set to visit Japan, Saudi Arabia and Turkey in October and November, but there is no confirmed schedule yet for a trip to India despite an invitation from New Delhi. While speculation continues over a possible India visit later this year, people familiar with India-Bangladesh ties said no date has been finalised.

‘I have the choice to leave’: Gurgaon founder says no other Indian city offers him the same mix of lifestyle and earning opportunities; sparks debate
Sep 28, 2026
‘I have the choice to leave’: Gurgaon founder says no other Indian city offers him the same mix of lifestyle and earning opportunities; sparks debate

Deepak Abbot, co-founder of Indiagold, has sparked a debate over quality of life in Indian cities after saying Gurgaon offers him a combination of lifestyle and earning opportunities that he has not found elsewhere. His comments on X drew mixed reactions, with users praising Gurgaon while others pointed to Chandigarh and the challenges faced across Indian cities.

China is building a new rulebook for dealing with the US — tariffs are only the beginning of a much broader reset
Sep 28, 2026
China is building a new rulebook for dealing with the US — tariffs are only the beginning of a much broader reset

China and the United States have established a reciprocal framework for tariff reductions on approximately $30 billion of goods from each side. They created two new boards to facilitate trading and investment discussions as a means of ongoing economic cooperation. Additionally, a dedicated dialogue on artificial intelligence (AI) issues has been initiated between the two nations. The Kuala Lumpur trade arrangement has also been extended for further negotiations.

Taliban claims success against Pakistan terrorists: 'Killed 28 fighters & wounded 32 others'
Sep 28, 2026
Taliban claims success against Pakistan terrorists: 'Killed 28 fighters & wounded 32 others'

Taliban has claimed that its forces killed 28 fighters and wounded 32 others in Afghanistan’s Nuristan province after alleged ISIS militants crossed the border from Pakistan. Afghanistan’s defence ministry said the group entered Kamdesh district with plans to carry out attacks and accused Pakistan-backed forces of supporting the infiltration. Pakistan has not yet responded to the claim.

Amit Shah unveils PRAHAAR, a whole-of-society strategy against terror
Sep 28, 2026
Amit Shah unveils PRAHAAR, a whole-of-society strategy against terror

Mentioning various steps undertaken for mitigating terrorist threats, he advocated institutionalizing an automated counter terrorism response at every level of the framework. Impressing upon the necessity of result-oriented approach towards each pillar of PRAHAAR, Shah called for coordination among the stakeholders to prevent any delay in action.

Amit Shah unveils PRAHAAR, a whole-of-society strategy against terror
Sep 28, 2026
Amit Shah unveils PRAHAAR, a whole-of-society strategy against terror

Mentioning various steps undertaken for mitigating terrorist threats, he advocated institutionalizing an automated counter terrorism response at every level of the framework. Impressing upon the necessity of result-oriented approach towards each pillar of PRAHAAR, Shah called for coordination among the stakeholders to prevent any delay in action.

What is Anthropic Claude Sonnet 5.5?
Sep 28, 2026
What is Anthropic Claude Sonnet 5.5?

Anthropic has released Claude Sonnet 5.5 on Monday. It is the second model in its Claude 5.5 family. The AI lab is expanding its product lineup ahead of a planned IPO. Sonnet 5.5 is a faster and lower-cost option than Claude Opus 5.5.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Daily World Feed

Get yourself immersed in engaging topics right here. Daily World Feed is a multi-platform media, providing you latest breaking news straight from the industry.

Sign Up